언어 선택

Neurogranin

Neurogranin 제품 목록

속성
Protein (1)
제품 라이브러리
온라인 (1)
종
Human (1)
태그
His Tag (1)
마커
Unconjugated (1)

제품 번호	종	발현 시스템	제품 설명	단백질 구조	순도	특성
NEN-H5144	Human	E. coli	Human Neurogranin Protein, His Tag

총 수량1

Neurogranin분자 배경

Neurogranin is as a small protein encoded by the NRGN gene. it is a calmodulin-binding protein expressed primarily in the brain, particularly in dendritic spines, and participating in the protein kinase C signaling pathway. Neurogranin is the main postsynaptic protein regulating the availability of calmodulin, binding to it in the absence of calcium. Phosphorylation by protein kinase C lowers its binding ability. It is a potential biomarker of neurological and mental diseases.

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
Semzuvolimab	dB4; UB-421; mAb-B4	Phase 3 Clinical	United Biomedical Inc	HIV Infections	상세
ITV 1(Nonindustrial source)	ITV-1	Phase 3 Clinical	Synexa Life Sciences, Immunotech Laboratories	HIV Infections	상세
RB-0003	RB-0003; BNT-111	Phase 2 Clinical	Biontech Se, Tron	Melanoma	상세
VRC-01-LS	VRC-HIVMAB-080-00-AB; VRC-01-LS	Phase 2 Clinical	National Institute Of Allergy And Infectious Diseases (Niaid)	HIV Infections	상세
VRC-07-523	VRC-07-523-L S; VRC-HIVMAB075-00-AB; VRC-HIVMAB-075 -00-AB; VRC-07-523; TMB-380	Phase 2 Clinical	National Institute Of Allergy And Infectious Diseases (Niaid), Taimed Biologics Inc	Acquired Immunodeficiency Syndrome; HIV Infections; Retroviridae Infections; Sexually Transmitted Diseases, Viral; HIV Seropositivity	상세
GEN-009	GEN-009	Phase 2 Clinical	Genocea Biosciences Inc	Skin Melanoma; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung	상세
Tregalizumab	hB-F5; BT-061	Phase 2 Clinical	Biotest Pharma Gmbh	Drug Hypersensitivity; Arthritis, Rheumatoid; Psoriasis; Asthma	상세
MVA-EL	MVA-EBNA1/LMP2	Phase 2 Clinical	Chinese University Of Hong Kong (Cuhk), Cancer Research UK	Head and Neck Neoplasms; Stomach Neoplasms; Nasopharyngeal Neoplasms; Lymphoproliferative Disorders; Epstein-Barr Virus Infections; Lymphoma	상세
VRC-HIVMAB091-00-AB	N6LS; Z258‐N6LS; VRC-HIVMAB091-00-AB	Phase 2 Clinical	National Institute Of Allergy And Infectious Diseases (Niaid)	HIV Infections	상세
IMCY-0141	IMCY-0141	Phase 2 Clinical	Imcyse Sa	Multiple Sclerosis, Relapsing-Remitting	상세
Autologous Regulatory Т-cell Therapy		Phase 2 Clinical	Institute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus	Scleroderma, Systemic	상세
CD4-directed chimeric antigen receptor engineered T-cells (Icell Gene)	CD4CAR (Icell Gene)	Phase 1 Clinical	Stony Brook University School Of Medicine, Icell Gene Therapeutics (Int'L) Ltd, University Of Louisville	Leukemia, Myelomonocytic, Chronic; Lymphoma, T-Cell; Leukemia, T-Cell	상세
T-allo-10	T-allo-10	Phase 1 Clinical	Stanford University	Hematologic Diseases; Leukemia; Graft vs Host Disease; Hodgkin Disease; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin	상세
Anti-CD4 CAR T-cell therapy (University of Pennsylvania)	CAR-C34ZFN	Phase 1 Clinical	University Of Pennsylvania	HIV Infections; HIV Seropositivity	상세
10E8.4/iMab (Aaron Diamond AIDS Research Center)	TMB-370	Phase 1 Clinical	Aaron Diamond Aids Research Center For The City Of New York, Inc	HIV Infections	상세
CALRLong36 peptide (Herlev Hospital)		Phase 1 Clinical	Herlev Hospital	Myeloproliferative Disorders	상세
VRC-HIVMAB060-00-AB	VRC-HIVMAB060-00-AB; VRC01	Phase 1 Clinical	National Institute Of Allergy And Infectious Diseases (Niaid)	HIV Infections	상세
VRC-HIVMAB0115-00-AB		Phase 1 Clinical	National Institute Of Allergy And Infectious Diseases (Niaid)	HIV Infections; HIV Seropositivity	상세
SCRI-E2CAR_EGFRtv1	SCRI-E2CAR_EGFRtv1	Phase 1 Clinical	Umoja BioPharma Inc	Osteosarcoma	상세
CD4^LVFOXP3 Treg-like cell therapy	CD4^LVFOXP3	Phase 1 Clinical	Stanford University	Polyendocrinopathies, Autoimmune	상세
TMB-365	TMB-365	Phase 1 Clinical	Taimed Biologics Inc	HIV Infections	상세
LB-1901	LB1901; LB-1901	Phase 1 Clinical		Lymphoma, T-Cell, Peripheral; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous	상세
IT-1208 (Kyowa Hakko Kirin)	IT-1208	Phase 1 Clinical	Kyowa Hakko Kirin Co Ltd	Neoplasms	상세

시판 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	가장 빠른 브랜드 이름	가장 빠른 승인 국가	가장 빠른 적응증	가장 빠른 승인 회사	가장 빠른 승인 날짜	적응증	임상 시험
Ibalizumab	Hu5A8; TMB-355; TNX-355; 5AB	Approved	Biogen Inc	特罗格佐, Trogarzo	United States	HIV Infections	Theratechnologies Inc	2018-03-06	HIV Infections	상세